ASX - By Stock
|
EOS |
Re:
Ann: Response to ASX Price Query
|
|
bowlerau
|
6 |
3.3K |
2 |
13/02/24 |
13/02/24 |
ASX - By Stock
|
6
|
3.3K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Silvu Itescu
|
|
bowlerau
|
14 |
3.0K |
3 |
18/01/24 |
18/01/24 |
ASX - By Stock
|
14
|
3.0K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Silvu Itescu
|
|
bowlerau
|
14 |
3.0K |
1 |
18/01/24 |
18/01/24 |
ASX - By Stock
|
14
|
3.0K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Silvu Itescu
|
|
bowlerau
|
14 |
3.0K |
0 |
18/01/24 |
18/01/24 |
ASX - By Stock
|
14
|
3.0K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Silvu Itescu
|
|
bowlerau
|
14 |
3.0K |
1 |
18/01/24 |
18/01/24 |
ASX - By Stock
|
14
|
3.0K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
$30 Billion Deal
|
|
bowlerau
|
4.9K |
1.3M |
2 |
08/11/23 |
08/11/23 |
ASX - By Stock
|
4.9K
|
1.3M
|
2
|
|
ASX - By Stock
|
WBC |
Re:
Ann: Westpac's Full Year 2023 Notable Items
|
|
bowlerau
|
62 |
19K |
1 |
26/10/23 |
26/10/23 |
ASX - By Stock
|
62
|
19K
|
1
|
|
ASX - By Stock
|
COL |
Re:
Trading Analysis
|
|
bowlerau
|
47 |
24K |
1 |
20/10/23 |
20/10/23 |
ASX - By Stock
|
47
|
24K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Annual Report/Notice of Annual General Meeting/Proxy Form
|
|
bowlerau
|
56 |
16K |
0 |
20/10/23 |
20/10/23 |
ASX - By Stock
|
56
|
16K
|
0
|
|
ASX - By Stock
|
SE1 |
Re:
Ann: Notice of Extraordinary General Meeting/Proxy Form
|
|
bowlerau
|
11 |
5.0K |
0 |
11/08/23 |
11/08/23 |
ASX - By Stock
|
11
|
5.0K
|
0
|
|
ASX - By Stock
|
SE1 |
Re:
Ann: Notice of Extraordinary General Meeting/Proxy Form
|
|
bowlerau
|
11 |
5.0K |
0 |
08/08/23 |
08/08/23 |
ASX - By Stock
|
11
|
5.0K
|
0
|
|
ASX - By Stock
|
SE1 |
Re:
Ann: Notice of Extraordinary General Meeting/Proxy Form
|
|
bowlerau
|
11 |
5.0K |
0 |
07/08/23 |
07/08/23 |
ASX - By Stock
|
11
|
5.0K
|
0
|
|
ASX - By Stock
|
SE1 |
Re:
Ann: Notice of Extraordinary General Meeting/Proxy Form
|
|
bowlerau
|
11 |
5.0K |
2 |
07/08/23 |
07/08/23 |
ASX - By Stock
|
11
|
5.0K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
FDA could approve it for the children
|
|
bowlerau
|
21 |
6.3K |
1 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
21
|
6.3K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
FDA could approve it for the children
|
|
bowlerau
|
21 |
6.3K |
2 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
21
|
6.3K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
bowlerau
|
1.0K |
389K |
7 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
1.0K
|
389K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
bowlerau
|
1.0K |
389K |
1 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
1.0K
|
389K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
bowlerau
|
1.0K |
389K |
2 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
1.0K
|
389K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
bowlerau
|
1.0K |
389K |
2 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
1.0K
|
389K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
bowlerau
|
1.0K |
389K |
15 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
1.0K
|
389K
|
15
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
bowlerau
|
1.0K |
389K |
19 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
1.0K
|
389K
|
19
|
|
ASX - By Stock
|
SE1 |
Re:
Capital Loss
|
|
bowlerau
|
12 |
8.2K |
0 |
23/06/23 |
23/06/23 |
ASX - By Stock
|
12
|
8.2K
|
0
|
|
ASX - By Stock
|
ASB |
Re:
Ann: Austal awarded US$3 billion T-AGOS contract for US Navy
|
|
bowlerau
|
93 |
29K |
2 |
19/05/23 |
19/05/23 |
ASX - By Stock
|
93
|
29K
|
2
|
|
ASX - By Stock
|
SE1 |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
bowlerau
|
8 |
3.8K |
5 |
28/04/23 |
28/04/23 |
ASX - By Stock
|
8
|
3.8K
|
5
|
|
ASX - By Stock
|
EOS |
Re:
News: EOS Electro Optic Systems Secures Conditional Contract To Supply Remote Weapon Systems To...
|
|
bowlerau
|
28 |
20K |
2 |
03/04/23 |
03/04/23 |
ASX - By Stock
|
28
|
20K
|
2
|
|
ASX - By Stock
|
SE1 |
Re:
Ann: Half Year Accounts - Appendix 4D
|
|
bowlerau
|
2 |
1.5K |
1 |
02/03/23 |
02/03/23 |
ASX - By Stock
|
2
|
1.5K
|
1
|
|
ASX - By Stock
|
SE1 |
Re:
Ann: Monthly Activities/Appendix 4C Cash Flow Report
|
|
bowlerau
|
6 |
5.4K |
7 |
31/01/23 |
31/01/23 |
ASX - By Stock
|
6
|
5.4K
|
7
|
|
ASX - By Stock
|
SE1 |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
bowlerau
|
30 |
13K |
3 |
02/12/22 |
02/12/22 |
ASX - By Stock
|
30
|
13K
|
3
|
|
ASX - By Stock
|
SE1 |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
bowlerau
|
30 |
13K |
1 |
03/11/22 |
03/11/22 |
ASX - By Stock
|
30
|
13K
|
1
|
|
ASX - By Stock
|
SE1 |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
bowlerau
|
30 |
13K |
3 |
19/10/22 |
19/10/22 |
ASX - By Stock
|
30
|
13K
|
3
|
|
ASX - By Stock
|
SE1 |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
bowlerau
|
10 |
5.9K |
3 |
11/10/22 |
11/10/22 |
ASX - By Stock
|
10
|
5.9K
|
3
|
|
ASX - By Stock
|
ASB |
Re:
AUSTAL Launches It's Largest Ferry Ever.
|
|
bowlerau
|
7 |
1.9K |
0 |
03/10/22 |
03/10/22 |
ASX - By Stock
|
7
|
1.9K
|
0
|
|
ASX - By Stock
|
SE1 |
Re:
Ann: Final Director's Interest Notice
|
|
bowlerau
|
3 |
1.3K |
2 |
28/09/22 |
28/09/22 |
ASX - By Stock
|
3
|
1.3K
|
2
|
|
ASX - By Stock
|
SE1 |
Re:
Ann: Suspension from commencement of trading today
|
|
bowlerau
|
52 |
22K |
2 |
12/09/22 |
12/09/22 |
ASX - By Stock
|
52
|
22K
|
2
|
|
ASX - By Stock
|
SE1 |
Re:
Ann: Suspension from commencement of trading today
|
|
bowlerau
|
52 |
22K |
1 |
08/09/22 |
08/09/22 |
ASX - By Stock
|
52
|
22K
|
1
|
|
ASX - By Stock
|
SE1 |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
bowlerau
|
7 |
2.5K |
1 |
31/08/22 |
31/08/22 |
ASX - By Stock
|
7
|
2.5K
|
1
|
|
ASX - By Stock
|
AR9 |
Re:
Ann: Appendix 4E & 2022 Annual Report
|
|
bowlerau
|
49 |
11K |
0 |
25/08/22 |
25/08/22 |
ASX - By Stock
|
49
|
11K
|
0
|
|
ASX - By Stock
|
SE1 |
Re:
Ann: Suspension from commencement of trading today
|
|
bowlerau
|
52 |
22K |
2 |
03/08/22 |
03/08/22 |
ASX - By Stock
|
52
|
22K
|
2
|
|
ASX - By Stock
|
EOS |
Re:
Ann: Interim Acting Chief Financial Officer Update
|
|
bowlerau
|
3 |
2.0K |
0 |
19/07/22 |
19/07/22 |
ASX - By Stock
|
3
|
2.0K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Director Appointment
|
|
bowlerau
|
213 |
58K |
0 |
24/03/22 |
24/03/22 |
ASX - By Stock
|
213
|
58K
|
0
|
|
ASX - By Stock
|
ASB |
Re:
Ann: Philippines OPV update
|
|
bowlerau
|
43 |
15K |
4 |
23/03/22 |
23/03/22 |
ASX - By Stock
|
43
|
15K
|
4
|
|
ASX - By Stock
|
ASB |
Re:
The way forward
|
|
bowlerau
|
50 |
12K |
0 |
08/03/22 |
08/03/22 |
ASX - By Stock
|
50
|
12K
|
0
|
|
ASX - By Stock
|
EOS |
Re:
what happened to EOS today ?
|
|
bowlerau
|
404 |
187K |
3 |
08/03/22 |
08/03/22 |
ASX - By Stock
|
404
|
187K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDAs OTAT Agrees to Primary Endpoint for Back Pain
|
|
bowlerau
|
408 |
123K |
4 |
17/12/21 |
17/12/21 |
ASX - By Stock
|
408
|
123K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDAs OTAT Agrees to Primary Endpoint for Back Pain
|
|
bowlerau
|
408 |
123K |
5 |
17/12/21 |
17/12/21 |
ASX - By Stock
|
408
|
123K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDAs OTAT Agrees to Primary Endpoint for Back Pain
|
|
bowlerau
|
408 |
123K |
1 |
17/12/21 |
17/12/21 |
ASX - By Stock
|
408
|
123K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDAs OTAT Agrees to Primary Endpoint for Back Pain
|
|
bowlerau
|
408 |
123K |
0 |
17/12/21 |
17/12/21 |
ASX - By Stock
|
408
|
123K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDAs OTAT Agrees to Primary Endpoint for Back Pain
|
|
bowlerau
|
408 |
123K |
0 |
17/12/21 |
17/12/21 |
ASX - By Stock
|
408
|
123K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDAs OTAT Agrees to Primary Endpoint for Back Pain
|
|
bowlerau
|
408 |
123K |
1 |
17/12/21 |
17/12/21 |
ASX - By Stock
|
408
|
123K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on Novartis Agreement
|
|
bowlerau
|
850 |
249K |
18 |
14/12/21 |
14/12/21 |
ASX - By Stock
|
850
|
249K
|
18
|
|